These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38509247)

  • 21. The Triglyceride-Glucose Index is Associated with Vitamin D Status in Metabolic-Associated Fatty Liver Disease.
    Liu Z; Zhang W; Zhao Z; Li W; Zhang J
    Diabetes Metab Syndr Obes; 2023; 16():2651-2660. PubMed ID: 37670850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study.
    Lee H; Lee YH; Kim SU; Kim HC
    Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2138-2147.e10. PubMed ID: 33348045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
    Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
    BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between Vitamin D Status and Non-Alcoholic Fatty Liver Disease: A Population-Based Study.
    Liu S; Liu Y; Wan B; Zhang H; Wu S; Zhu Z; Lin Y; Wang M; Zhang N; Lin S; Zhu Y
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(4):303-308. PubMed ID: 31474679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease.
    Yang C; He Q; Chen Z; Qin JJ; Lei F; Liu YM; Liu W; Chen MM; Sun T; Zhu Q; Wu Y; Zhuo M; Cai J; Mao W; Li H
    Front Endocrinol (Lausanne); 2022; 13():821689. PubMed ID: 35250880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study.
    Hu Q; Chen Y; Bao T; Huang Y
    Ren Fail; 2022 Dec; 44(1):1996-2005. PubMed ID: 36374233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic associated fatty liver disease is a risk factor for chronic kidney disease.
    Hashimoto Y; Hamaguchi M; Okamura T; Nakanishi N; Obora A; Kojima T; Fukui M
    J Diabetes Investig; 2022 Feb; 13(2):308-316. PubMed ID: 34561962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic fatty liver disease without overlapping metabolic-associated fatty liver disease and the risk of incident type 2 diabetes.
    Cho Y; Chang Y; Ryu S; Wild SH; Byrne CD
    Liver Int; 2023 Nov; 43(11):2445-2454. PubMed ID: 37387519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients.
    Zhang W; Li Y; Li S; Zhou J; Wang K; Li Z; Chen N; Chen X
    Front Endocrinol (Lausanne); 2023; 14():1278505. PubMed ID: 38116314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes.
    Cipponeri E; Vitturi N; Mariano V; Boscari F; Galasso S; Crepaldi C; Fadini GP; Vigili de Kreutzenberg S; Marescotti MC; Iori E; Cavallin F; Sartori L; Baritussio A; Avogaro A; Bruttomesso D
    J Endocrinol Invest; 2019 Sep; 42(9):1099-1107. PubMed ID: 30847862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between cataract and fatty liver diseases from a nationwide cross-sectional study in South Korea.
    Kang KH; Shin D; Ryu IH; Kim JK; Lee IS; Koh K; Yoo TK
    Sci Rep; 2024 Jan; 14(1):77. PubMed ID: 38167592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study.
    Lee SM; Cho GJ; Wi WY; Norwitz ER; Koo BK; Lee J; Jung YM; Kwak SH; Park CW; Jun JK; Joo SK; Oh MJ; Kim W; Park JS
    Hepatol Int; 2023 Apr; 17(2):367-376. PubMed ID: 36542262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn's disease but not Ulcerative Colitis: a prospective cohort study.
    Chen J; Dan L; Tu X; Sun Y; Deng M; Chen X; Hesketh T; Li R; Wang X; Li X
    Hepatol Int; 2023 Feb; 17(1):202-214. PubMed ID: 36194337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Metabolic Dysfunction-Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study.
    Wei S; Song J; Xie Y; Huang J; Yang J
    JMIR Public Health Surveill; 2023 May; 9():e45050. PubMed ID: 37140958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between metabolic dysfunction-associated fatty liver disease and low muscle mass in an asymptomatic Korean population.
    Seo JY; Cho EJ; Kim MJ; Kwak MS; Yang JI; Chung SJ; Yim JY; Yoon JW; Chung GE
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2953-2960. PubMed ID: 36222309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease.
    Guo B; Guo Y; Nima Q; Feng Y; Wang Z; Lu R; Baimayangji ; Ma Y; Zhou J; Xu H; Chen L; Chen G; Li S; Tong H; Ding X; Zhao X;
    J Hepatol; 2022 Mar; 76(3):518-525. PubMed ID: 34883157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease.
    Moon JH; Kim W; Koo BK; Cho NH;
    Gut Liver; 2022 May; 16(3):433-442. PubMed ID: 34635626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiometabolic characterization in metabolic dysfunction-associated fatty liver disease.
    Perdomo CM; Núñez-Córdoba JM; Ezponda A; Mendoza FJ; Ampuero J; Bastarrika G; Frühbeck G; Escalada J
    Front Med (Lausanne); 2022; 9():1023583. PubMed ID: 36341262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low serum vitamin D is independently associated with unexplained elevated ALT only among non-obese men in the general population.
    Zelber-Sagi S; Zur R; Thurm T; Goldstein A; Ben-Assuli O; Chodick G; Shibolet O
    Ann Hepatol; 2019; 18(4):578-584. PubMed ID: 31103458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study.
    Zhang Y; Xia Z; Cai X; Su X; Jin A; Mei L; Jing J; Wang S; Meng X; Li S; Wang M; Wei T; Wang Y; He Y; Pan Y
    Cardiovasc Diabetol; 2023 Dec; 22(1):342. PubMed ID: 38093371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.